Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Arcion raises funds in Series A financing to help develop ARC-4558 for pain

Jan. 14, 2008

Somaxon completes 26-week transgenic mouse carcinogenicity study of Silenor

Jan. 14, 2008

Novel analgesic agents reported in patent literature

Jan. 11, 2008

CTS-21166 reduces plasma amyloid beta in phase I study

Jan. 11, 2008

Pipex initiates phase II trial of anti-copper Coprexa for Alzheimer's disease

Jan. 11, 2008

Quetiapine treatment assessed in depression, anxiety and alcoholism

Jan. 11, 2008

Iloperidone effective in double-blind schizophrenia trials

Jan. 11, 2008

Erythropoietin may have antidepressant activity

Jan. 11, 2008

Therapeutic potential of GLS1 inhibition in schizophrenia

Jan. 10, 2008

Ambien CR tablets CIV improve chronic insomnia in GAD patients

Jan. 10, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...